Circulating tumor DNA-guided therapeutic strategies for metastatic colorectal cancer patients with multiple small pulmonary-limited nodules: A prospective cohort study.
Blood tumor DNA changes predicted cancer progression earlier than standard imaging, though these findings remain exploratory and need prospective testing.
This prospective cohort study examined prognostic and treatment-guidance utility of longitudinal circulating tumor DNA monitoring. Longitudinal circulating tumor DNA anticipated extrapulmonary progression and stratified progression risk, but the findings remain exploratory.
What the study was
- Study design
- Prospective cohort study
- Population
- 70 patients with metastatic colorectal cancer and small pulmonary-limited nodules
- Sample size
- 70
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- European journal of cancer (Oxford, England : 1990)
Why it surfaced
Retained as a standard-priority prospective cohort study after PubMed abstract review; the score reflects clinical relevance, design strength, novelty, and population need under the v1.3 conservative rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.